4-{[(11beta)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid(CAS: 83784-20-7)

4-{[(11beta)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid (CAS: 83784-20-7) is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. It is important to adhere to local and international guidelines for storage, handling, and disposal to ensure safety and environmental protection.

In the synthesis of 4-{[(11beta)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid (CAS: 83784-20-7), there are no direct alternatives, but similar compounds like progesterone derivatives can be used as analogs. Common alternative reagents include various catalysts and solvents that can improve the yield and purity of the final product.

The market for 4-{[(11beta)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid (CAS: 83784-20-7) is driven by its applications in pharmaceutical research and development. Emerging trends include the exploration of its potential in reproductive health and hormone-related therapies. Research is focusing on understanding its biological activity and improving synthesis methods to enhance its therapeutic value.

Waste containing 4-{[(11beta)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid (CAS: 83784-20-7) should be collected in a sealed, labeled container and disposed of according to local hazardous waste regulations. Professional waste disposal services are recommended for safe incineration or other environmentally friendly processes. Proper training and protective equipment are necessary to ensure safety during handling.